
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Notch 4 CRISPR/Cas9 KO Plasmid (m) | sc-421934 | 20 µg | $397.00 |
Notch4 encodes a single-pass transmembrane receptor in the Notch family that mediates contact-dependent signaling controlling cell fate decisions, proliferation, and differentiation. Upon ligand engagement by Delta-like or Jagged proteins, receptor proteolysis releases the Notch intracellular domain to regulate transcriptional programs in coordination with RBPJ/CSL and co-activators. In mouse tissues, Notch4 is strongly linked to vascular and endothelial biology, influencing angiogenic behavior and vessel maturation through crosstalk with pathways such as VEGF, Wnt, and TGF-β. Dysregulated Notch4 signaling has been associated with aberrant vascular remodeling and tumor-associated angiogenesis, making it relevant for mechanistic studies of developmental and disease-associated signaling networks.
Notch 4 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Notch4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Notch4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Notch4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Notch 4 protein expression.
This CRISPR knockout system enables efficient generation of Notch4-deficient cell models for investigation of Notch 4 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.